Discovery of the clinical candidate BMS-816336, an adamantyl acetamide based 11β-hydroxysteroid dehydrogenase type-1 (11β-HSD1) inhibitor

被引:0
作者
Ye, Xiang-Yang [1 ]
Chen, Stephanie [1 ]
Wu, Shung [1 ]
Yoon, David [1 ]
Wang, Haixia [1 ]
Hong, Zhengqiu [1 ]
Oconnor, Stephen [1 ]
Li, James [1 ]
Li, Jun [1 ]
Walker, Steven [1 ]
Kennedy, Lawrence [1 ]
Apedo, Atsu [1 ]
Nayeem, Akbar [1 ]
Sheriff, Steven [1 ]
Morin, Paul [1 ]
Camac, Daniel [1 ]
Harrity, Thomas [1 ]
Zebo, Rachel [1 ]
Taylor, Joseph [1 ]
Morgan, Nathan [1 ]
Ponticiello, Randolph [1 ]
Golla, Rajasree [1 ]
Seethala, Ramakrishna [1 ]
Wang, Mengmeng [1 ]
Harper, Timothy [1 ]
Sleczka, Bogdan [1 ]
He, Bin [1 ]
Kirby, Mark [1 ]
DiMarco, John [1 ]
Scaringe, Raymond [1 ]
Hanson, Ronald [1 ]
Guo, Zhiwei [1 ]
Li, Jianqing [1 ]
Sun, Jung-Hui [1 ]
Wong, Michael [1 ]
Chen, Bang-Chi [1 ]
Haque, Lauren [1 ]
Leahy, David [1 ]
Chan, Collin [1 ]
Li, Yi-Xin [1 ]
Zvyaga, Tatyana [1 ]
Hansen, Lars [1 ]
Patel, Chirag [1 ]
Gordon, David [1 ]
Robl, Jeffrey [1 ]
机构
[1] Bristol Myers Squibb, Princeton, NJ USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
25
引用
收藏
页数:2
相关论文
empty
未找到相关数据